These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33386805)

  • 21. Alzheimer's disease and amnestic mild cognitive impairment weaken connections within the default-mode network: a multi-modal imaging study.
    Zhu DC; Majumdar S; Korolev IO; Berger KL; Bozoki AC
    J Alzheimers Dis; 2013; 34(4):969-84. PubMed ID: 23313926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Huang KL; Hsiao IT; Kuo HC; Hsieh CJ; Hsieh YC; Wu YM; Wey SP; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2019 Sep; 118(9):1325-1332. PubMed ID: 30579663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer's Disease.
    Zhang Z; Chen G; Zhang J; Yan T; Go R; Fukuyama H; Wu J; Han Y; Li C
    Curr Alzheimer Res; 2020; 17(2):168-176. PubMed ID: 32148194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of longitudinal subcortical atrophy over one year in amnestic mild cognitive impairment and its impact on cognitive performance: a preliminary study.
    Çavuşoğlu B; Hünerli D; Emek Savaş DD; Yener G; Ada E
    Turk J Med Sci; 2024; 54(3):588-597. PubMed ID: 39049994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and structural alterations of dorsal attention network in preclinical and early-stage Alzheimer's disease.
    Wu H; Song Y; Yang X; Chen S; Ge H; Yan Z; Qi W; Yuan Q; Liang X; Lin X; Chen J
    CNS Neurosci Ther; 2023 Jun; 29(6):1512-1524. PubMed ID: 36942514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
    Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
    Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric Assessment of Hippocampus and Subcortical Gray Matter Regions in Alzheimer Disease and Amnestic Mild Cognitive Impairment.
    Topkan TA; Erdogan N; Barutcu B; Cindil E; Tali ET; Karaman Y
    Cogn Behav Neurol; 2022 Jun; 35(2):95-103. PubMed ID: 35639010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent Connectivity Changes in Gray Matter Structural Covariance Networks in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; He Y; Wang X; Lu J; Li S; Li X; Kang G; Han Y; Li S
    Front Aging Neurosci; 2021; 13():686598. PubMed ID: 34483878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
    Yan T; Wang Y; Weng Z; Du W; Liu T; Chen D; Li X; Wu J; Han Y
    J Alzheimers Dis; 2019; 68(3):1013-1027. PubMed ID: 30958352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter degeneration in subjective cognitive decline: a diffusion tensor imaging study.
    Li XY; Tang ZC; Sun Y; Tian J; Liu ZY; Han Y
    Oncotarget; 2016 Aug; 7(34):54405-54414. PubMed ID: 27384675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    Wang P; Zhou B; Yao H; Xie S; Feng F; Zhang Z; Guo Y; An N; Zhou Y; Zhang X; Liu Y
    J Alzheimers Dis; 2020; 75(4):1153-1168. PubMed ID: 32390630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalamic volume loss as an early sign of amnestic mild cognitive impairment.
    Zidan M; Boban J; Bjelan M; Todorović A; Stankov Vujanić T; Semnic M; Boban N; Kozić D
    J Clin Neurosci; 2019 Oct; 68():168-173. PubMed ID: 31324472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
    PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rich club disturbances of the human connectome from subjective cognitive decline to Alzheimer's disease.
    Yan T; Wang W; Yang L; Chen K; Chen R; Han Y
    Theranostics; 2018; 8(12):3237-3255. PubMed ID: 29930726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.
    Peng GP; Feng Z; He FP; Chen ZQ; Liu XY; Liu P; Luo BY
    CNS Neurosci Ther; 2015 Jan; 21(1):15-22. PubMed ID: 25146658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between Levels of Peripheral NCAPH2 Promoter Methylation and Different Stages of Alzheimer's Disease: A Cross-Sectional Study.
    Hao SW; Li TR; Han C; Han Y; Cai YN
    J Alzheimers Dis; 2023; 92(3):899-909. PubMed ID: 36806511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.